Zota Health Care Limited
Fundamental Score
Zota Health Care Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ZOTA across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Revenue Growth (91.66%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (25.23% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Balanced Promoter Holding (55.81%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Risk Factors
8 factors identified
Below-Average Return on Equity (-35.96%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-16.98%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (2.90%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Profit Decline Concern (-31.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (-3.98x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-123.55 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 8.44%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Financial Statements
Comprehensive financial data for Zota Health Care Limited
About ZOTA
Business Overview
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.
Company Details
Key Leadership
Corporate Events
ZOTA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Zota Health Care Limited (ZOTA)?
As of 30 Jan 2026, 01:35 pm IST, Zota Health Care Limited (ZOTA) is currently trading at ₹1288.50. The stock has a market capitalization of ₹5.00K (Cr).
Is ZOTA share price Overvalued or Undervalued?
ZOTA is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Zota Health Care Limited share price?
Key factors influencing ZOTA's price include its quarterly earnings growth (Sales Growth: 91.66%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Zota Health Care Limited a good stock for long-term investment?
Zota Health Care Limited shows a 5-year Profit Growth of N/A% and an ROE of -35.96%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.57 before investing.
How does Zota Health Care Limited compare with its industry peers?
Zota Health Care Limited competes with major peers in the Pharmaceuticals. Investors should compare ZOTA's P/E of 0.00x and ROE of -35.96% against the industry averages to determine its competitive standing.
What is the P/E ratio of ZOTA and what does it mean?
ZOTA has a P/E ratio of N/Ax compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is ZOTA performing according to Bull Run's analysis?
ZOTA has a Bull Run fundamental score of 24.8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ZOTA belong to?
ZOTA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Zota Health Care Limited.
What is Return on Equity (ROE) and why is it important for ZOTA?
ZOTA has an ROE of -35.96%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Zota Health Care Limited generates profits from shareholders' equity.
How is ZOTA's debt-to-equity ratio and what does it indicate?
ZOTA has a debt-to-equity ratio of 0.57, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is ZOTA's dividend yield and is it a good dividend stock?
ZOTA offers a dividend yield of 0.06%, which means you receive ₹0.06 annual dividend for every ₹100 invested.
How has ZOTA grown over the past 5 years?
ZOTA has achieved 5-year growth rates of: Sales Growth 25.23%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ZOTA and why does it matter?
Promoters hold 55.81% of ZOTA shares, with 0.26% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ZOTA's market capitalization category?
ZOTA has a market capitalization of ₹4997 crores, placing it in the Small-cap category.
How volatile is ZOTA stock?
ZOTA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ZOTA?
ZOTA has a 52-week high of ₹N/A and low of ₹N/A.
What is ZOTA's operating profit margin trend?
ZOTA has a 5-year average Operating Profit Margin (OPM) of 2.90%, indicating the company's operational efficiency.
How is ZOTA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 91.66% and YoY Profit Growth of -31.82%.
What is the institutional holding pattern in ZOTA?
ZOTA has FII holding of 3.49% and DII holding of 4.95%. Significant institutional holding often suggests professional confidence in the stock.